UiB-research sheds light on how CVD is associated with hypertensive disorders of pregnancy – but not for everyone.
Spear Bio secures $45 million in oversubscribed Series A financing to accelerate product launch for protein research and disease diagnostics
WOBURN, Mass.–(BUSINESS WIRE)–Spear Bio Inc., a biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment, announced the